Change in largest shareholder, a major shareholder
WAKAMOTO PHARMACEUTICAL CO.,LTD., Asset Value Investors Limited, ROHTO PHARMACEUTICAL CO.,LTD.
Change in voting rights ownership ratio
The voting rights ownership percentage is the proportion of the voting rights exercisable at a shareholders' meeting held by the shareholder.
Asset Value Investors Limited: 36,931 voting rights (3,693,100 shares), 10.65%, third-largest (as of 30 December 2025). ROHTO PHARMACEUTICAL CO.,LTD.: 39,719 voting rights (3,971,900 shares), 11.46%, largest (as of 31 March 2026).
Asset Value Investors Limited: 40,560 voting rights (4,056,000 shares), 11.70%, largest (as of 20 August 2026). ROHTO PHARMACEUTICAL CO.,LTD.: 39,719 voting rights (3,971,900 shares), 11.46%, second-largest (as of 20 August 2026).
Related procedures
Submission of a Large Shareholding Report (Change Report)
Kanto Local Finance Bureau
There are no matters requiring particular disclosure regarding the outlook at this time.
This matter is based on the filing of a Large-Shareholding Report (Amendment Report), and no matters requiring specific disclosure regarding the outlook are stated.
| Item | Details |
|---|---|
| Event name | Change in largest shareholder, a major shareholder |
| Date of occurrence | 20 August 2026 (date of change) |
| Date recognized / date notice received | 27 August 2026 (confirmed by the Company through the filing of a Large-Shareholding Report (Amendment Report)) |
| Subject Entity | WAKAMOTO PHARMACEUTICAL CO.,LTD., Asset Value Investors Limited, ROHTO PHARMACEUTICAL CO.,LTD. |
| Impact on Earnings Forecast | There are no matters requiring particular disclosure regarding the outlook at this time. |
| Type of litigation or proceeding | Submission of a Large Shareholding Report (Change Report) |
| Court or authority | Kanto Local Finance Bureau |
| Voting rights ownership percentage before the change | Asset Value Investors Limited: 36,931 voting rights (3,693,100 shares), 10.65%, third-largest (as of 30 December 2025). ROHTO PHARMACEUTICAL CO.,LTD.: 39,719 voting rights (3,971,900 shares), 11.46%, largest (as of 31 March 2026). |
| Voting rights ownership percentage after the change | Asset Value Investors Limited: 40,560 voting rights (4,056,000 shares), 11.70%, largest (as of 20 August 2026). ROHTO PHARMACEUTICAL CO.,LTD.: 39,719 voting rights (3,971,900 shares), 11.46%, second-largest (as of 20 August 2026). |
| Outlook | This matter is based on the filing of a Large-Shareholding Report (Amendment Report), and no matters requiring specific disclosure regarding the outlook are stated. |
Items this document does not state (15)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The Company confirmed the change in its major shareholder that is also its largest shareholder after a Large-Shareholding Report (Amendment Report) was filed with the Kanto Local Finance Bureau on 27 August 2026. No specific reason for the increase or decrease in shareholdings was stated.